Pierre, N., Huynh-Thu, V. A., Baiwir, D., VIEUJEAN, S., Bequet, E., Reenaers, C., Van Kemseke, C., Salée, C., Massot, C., Fleron, M., Mazzucchelli, G., Trzpiot, L., Eppe, G., De Pauw, E., Louis, E., & Meuwis, M.-A. (02 February 2024). Distinct blood protein profiles associated with ileal and colonic ulcers in Crohn’s disease [Poster presentation]. Belgian Week of Gastroenterology 2024, Antwerp, Belgium. |
MONIN, L., Reenaers, C., Grandfils, S., Latour, P., Van Kemseke, C., KROPP, S., Louis, E., & VIEUJEAN, S. (2024). Outcomes in patients stopping biologic during the first trimester of pregnancy : a retrospective monocentric study [Poster presentation]. Belgian Week of Gastroenterology 2024. |
MONIN, L., Reenaers, C., Grandfils, S., Latour, P., Van Kemseke, C., KROPP, S., Louis, E., & VIEUJEAN, S. (2024). Outcomes in patients stopping biologic during the first trimester of pregnancy : a retrospective monocentric study [Poster presentation]. European Crohn's and Colitis Organisation 2024. |
Pierre, N., Huynh-Thu, V. A., Baiwir, D., VIEUJEAN, S., Bequet, E., Reenaers, C., Van Kemseke, C., Salée, C., Massot, C., Fleron, M., Mazzucchelli, G., Trzpiot, L., Eppe, G., De Pauw, E., Louis, E., & Meuwis, M.-A. (2024). Distinct blood protein profiles associated with ileal and colonic ulcers in Crohn’s disease [Poster presentation]. European Crohn's and Colitis Organisation 2024, Stockholm, Sweden. |
Pierre, N., Huynh-Thu, V. A., Baiwir, D., VIEUJEAN, S., Bequet, E., Reenaers, C., Van Kemseke, C., Salée, C., Massot, C., Fleron, M., Mazzucchelli, G., Trzpiot, L., Eppe, G., De Pauw, E., Louis, E., & Meuwis, M.-A. (2024). Distinct blood protein profiles associated with ileal and colonic ulcers in Crohn’s disease [Paper presentation]. Belgian Week of Gastroenterology 2024. |
Loly, J.-P., Vieujean, S., Reenaers, C., Van Kemseke, C., Seidel, L., Louis, E., & Somja, J. (2023). In-Depth Assessment of Endoscopic Remission in Inflammatory Bowel Disease Treated by Anti-TNF or Vedolizumab. Inflammatory Bowel Diseases. doi:10.1093/ibd/izad066 |
Gofflot, A., MONIN, L., Seidel, L., Reenaers, C., KROPP, S., Van Kemseke, C., Latour, P., Forthomme, B., Croisier, J.-L., Louis, E., & Vieujean, S. (March 2023). Impact of different types of physical activity in inflammatory bowel disease [Paper presentation]. 35th Belgian Week of Gastroenterology 2023. |
Gofflot, A., MONIN, L., Seidel, L., Reenaers, C., KROPP, S., Van Kemseke, C., Latour, P., Forthomme, B., Croisier, J.-L., Louis, E., & Vieujean, S. (March 2023). Impact of different types of physical activity in inflammatory bowel disease [Poster presentation]. 18th Congress of European Crohn's and Colitis Organisation 2023. |
Peyrin-Biroulet, L., Rahier, J.-F., Kirchgesner, J., Abitbol, V., Shaji, S., Armuzzi, A., Karmiris, K., Gisbert, J. P., Bossuyt, P., Helwig, U., Burisch, J., Yanai, H., Doherty, G. A., Magro, F., Molnar, T., Löwenberg, M., Halfvarson, J., Zagorowicz, E., Rousseau, H., ... Coutard, L. (Other coll.). (March 2023). I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease. Clinical Gastroenterology and Hepatology, 21 (3), 771-788.e10. doi:10.1016/j.cgh.2022.09.018 |
Vieujean, S., GILLARD, R., Calvaer, F., Chayeb, M., Seidel, L., Reenaers, C., KROPP, S., Van Kemseke, C., Latour, P., Louis, E., & Meunier, P. (March 2023). Assessment of therapeutic response in Crohn’s disease by dynamic contrast enhanced MRI [Poster presentation]. 35th Belgian Week of Gastroenterology 2023. |
Vieujean, S., GILLARD, R., Calvaer, F., Chayeb, M., Seidel, L., Reenaers, C., KROPP, S., Van Kemseke, C., Latour, P., Louis, E., & Meunier, P. (March 2023). Assessment of therapeutic response in Crohn’s disease by dynamic contrast enhanced MRI [Poster presentation]. 35th Belgian Week of Gastroenterology 2023. |
Loly, J.-P., Vieujean, S., Reenaers, C., Van Kemseke, C., Seidel, L., Somja, J., & Louis, E. (March 2022). Remission state in inflammatory bowel disease patients on anti-TNF or vedolizumab: a confocal endomicroscopy study [Paper presentation]. 34th Belgian Week of Gastroenterology 2022. |
AMICONE, C., Marques, C. C., Reenaers, C., Van Kemseke, C., Seidel, L., & Louis, E. (2022). Early Post-Operative Endoscopy Is Associated with Lower Surgical Recurrence of Crohn's Disease: A Retrospective Study of Three Successive Cohorts. Gastroenterology Research and Practice, 2022, 6341069. doi:10.1155/2022/6341069 |
LOLY, J.-P., VIEUJEAN, S., REENAERS, C., VAN KEMSEKE, C., SEIDEL, L., SOMJA, J., & LOUIS, E. (01 January 2022). P234 Remission state in Inflammatory Bowel Disease patients on anti TNF or vedolizumab: a confocal endomicroscopy study. Journal of Crohn's and Colitis, 16 (Supplement_1), 283-i283. doi:10.1093/ecco-jcc/jjab232.361 |
VIEUJEAN, S., LATOUR, P., COIMBRA MARQUES, C., DELVENNE, P., LOUIS, E., & VAN KEMSEKE, C. (2021). Unusual intra-rectal “laterally spreading tumour” in immunosuppressed patient with ulcerative colitis. Acta Gastro-Enterologica Belgica. doi:10.51821/84.3.018 |
De Schepper, H., Coremans, G., Denis, M. A., Dewint, P., Duinslaeger, M., Gijsen, I., Haers, P., Komen, N., Remue, C., Roelandt, P., Somers, M., Surmont, M., Van de Putte, D., Van den Broeck, S., VAN KEMSEKE, C., & De Looze, D. (2021). Belgian consensus guideline on the management of hemorrhoidal disease. Acta Gastro-Enterologica Belgica, 84 (1), 101-120. doi:10.51821/84.1.497 |
Monin, L., Dubois, S., REENAERS, C., VAN KEMSEKE, C., LATOUR, P., VAN DAELE, D., VIEUJEAN, S., SEIDEL, L., & Louis, E. (2021). Ustekinumab in bio-naïve and bio-failure Crohn's disease patients: Results from a « real-life » monocentric cohort. Digestive and Liver Disease. doi:10.1016/j.dld.2020.10.040 |
Kouam, C., WARLING, O., VAN KEMSEKE, C., LOLY, J.-P., Louis, E., & Delwaide, J. (2020). Risques néoplasiques majorés dans la rectocolite ulcéro-hémorragique associée à la cholangite sclérosante primitive. Revue Médicale de Liège, 75 (11), 724-730. |
Preda, C., Manuc, T., Chifulescu, A. E., Istratescu, D., Louis, E., Baicus, C., Sandra, I., Diculescu, M., Reenaers, C., VAN KEMSEKE, C., Nitescu, M., Tieranu, C., Popescu, M. C., Tugui, L., Andrei, A., Ciora, C.-A., Gheorghe, L.-S., & Manuc, M. (2020). Diet as an environmental trigger in inflammatory bowel disease: A retrospective comparative study in two European cohorts. Revista Espanola de Enfermedades Digestivas, 112 (6), 440-447. doi:10.17235/reed.2020.6552/2019 |
VIEUJEAN, S., BURY, T., GASPARD, L., GIOT, J.-B., MAWEJA, S., LOUIS, E., & VAN KEMSEKE, C. (February 2019). Ganglionic tuberculosis in a Crohn’s disease patient treated by infliximab despite anti-tuberculosis chemoprophylaxis [Paper presentation]. Belgian Week of Gastroenterology 31st Edition - BWGE 2019. |
Liefferinckx, C., Verstockt, B., Gils, A., Noman, M., VAN KEMSEKE, C., Macken, E., De Vos, M., Van Moerkercke, W., Rahier, J.-F., Bossuyt, P., Dutre, J., Humblet, E., Staessen, D., Peeters, H., Van Hootegem, P., Louis, E., Franchimont, D., Baert, F., & Vermeire, S. (2019). Long-term Clinical Effectiveness of Ustekinumab in Patients with Crohn's Disease Who Failed Biologic Therapies: A National Cohort Study. Journal of Crohn's & colitis, 13 (11), 1401-1409. doi:10.1093/ecco-jcc/jjz080 |
Pierre, N., Salee, C., MASSOT, C., BLETARD, N., Mazzucchelli, G., Smargiasso, N., Morsa, D., Baiwir, D., De Pauw, E., REENAERS, C., VAN KEMSEKE, C., LOLY, J.-P., Delvenne, P., Meuwis, M.-A., & Louis, E. (2019). Proteomics highlights common and distinct pathophysiological processes associated with ileal and colonic ulcers in Crohn's disease. Journal of Crohn's & colitis. doi:10.1093/ecco-jcc/jjz130 |
Preda, C. M., Manuc, T., Istratescu, D., Louis, E., Baicus, C., Sandra, I., Diculescu, M., REENAERS, C., VAN KEMSEKE, C., Nitescu, M., Tieranu, C., Sandu, C. G., Oprea-Calin, G., Tugui, L., Viziru, S., Ciora, C.-A., Gheorghe, L.-S., & Manuc, M. (2019). Environmental Factors in Romanian and Belgian Patients with Inflammatory Bowel Disease - a Retrospective Comparative Study. Mædica, 14 (3), 233-239. doi:10.26574/maedica.2019.14.3.233 |
Pierre, N., REENAERS, C., VAN KEMSEKE, C., LOLY, J.-P., Mazzucchelli, G., Smargiasso, N., Baiwir, D., De Pauw, E., MEUWIS, M.-A., & LOUIS, E. (February 2018). Proteomic analysis highlights divergences and convergences between ileal and colonic pathological processes involved in Crohn’s ulcers [Poster presentation]. 30th edition of the Belgian Week of Gastroenterology, Anvers, Belgium. |
Pierre, N., REENAERS, C., VAN KEMSEKE, C., LOLY, J.-P., Mazzucchelli, G., Smargiasso, N., Baiwir, D., Morsa, D., De Pauw, E., MEUWIS, M.-A., & Louis, E. (2018). Proteomic analysis highlights divergences and convergences between ileal and colonic pathological processes involved in Crohn’s ulcers. Journal of Crohn's and Colitis. doi:10.1093/ecco-jcc/jjx180.184 |
VIEUJEAN, S., LATOUR, P., COIMBRA MARQUES, C., LOUIS, E., & VAN KEMSEKE, C. (February 2018). Curious intra-rectal “laterally spreading tumor” in immunosuppressed patient with ulcerative colitis [Paper presentation]. Belgian Week of Gastroenterology 30th Edition - BWGE 2018. |
Bello, C., Roseth, A., Guardiola, J., REENAERS, C., Ruiz-Cerulla, A., VAN KEMSEKE, C., Arajol, C., Reinhard, C., SEIDEL, L., & Louis, E. (2017). Usability of a home-based test for the measurement of fecal calprotectin in asymptomatic IBD patients. Digestive and Liver Disease, 49 (9), 991-996. doi:10.1016/j.dld.2017.05.009 |
DESIR, C., COIMBRA MARQUES, C., Decker, M., REENAERS, C., VAN KEMSEKE, C., LATOUR, P., Louis, E., & Meunier, P. (2017). Comment j'explore ... la maladie de Crohn par imagerie. Revue Médicale de Liège, 72 (1), 51-56. |
LOLY, J.-P., SOMJA, J., REENAERS, C., VAN KEMSEKE, C., GAST, P., & Louis, E. (2017). Endomicroscopie confocale dans la prise en charge des maladies inflammatoires chroniques de l'intestin. Revue Médicale Suisse, 13 (571), 1431-1434. |
Louis, E., VAN KEMSEKE, C., & REENAERS, C. (2017). Objective assessment of clinical disease activity. In D. C. Baumgart (Ed.), Crohn's Disease and Ulcerative Colitis: From Epidemiology and Immunobiology to a Rational Diagnostic and Therapeutic Approach (pp. 259-266). Springer, Cham - D.C. Baumgart (ed.). doi:10.1007/978-3-319-33703-6_23 |
REENAERS, C., Pirard, C., VAN KEMSEKE, C., LATOUR, P., Belaiche, J., & Louis, E. (2016). Long-term evolution and predictive factors of mild inflammatory bowel disease. Scandinavian Journal of Gastroenterology, 51 (6), 712-9. doi:10.3109/00365521.2015.1128965 |
Bonnet, C., LEJEUNE, M., VAN KEMSEKE, C., Bron, D., & Beguin, Y. (2015). Prise en charge actuelle du lymphome de la zone marginale. Revue Médicale Suisse, 11, 1549-1556. |
Louis, E., REENAERS, C., VAN KEMSEKE, C., LATOUR, P., BELAICHE, J., MEUNIER, P., & COIMBRA MARQUES, C. (2015). De l'"Evidence-based Medecine" à la médecine personnalisée dans la maladie de Crohn. Revue Médicale de Liège, 70 (5-6), 316-320. |
MEUNIER, P., COUSIN, F., VAN KEMSEKE, C., REENAERS, C., LATOUR, P., BELAICHE, J., SEIDEL, L., & LOUIS, E. (2015). Persisting signs of disease activity at magnetic resonance enterocolonography predict clinical relapse and disease progression in quiescent Crohn's disease. Acta Gastro-Enterologica Belgica, 73 (3), 274-81. |
Van Kemseke, C., Louis, E., & REENAERS, C. (2015). LE MEDICAMENT DU MOIS. Vedolizumab (Entyvio(R)), nouveau traitement des maladies inflammatoires intestinales. Revue Médicale de Liège, 70 (11), 575-82. |
Poncin, M., REENAERS, C., VAN KEMSEKE, C., Belaiche, J., Seidel, L., MEUNIER, P., & Louis, E. (2014). Depth of remission in Crohn's disease patients seen in a referral centre : associated factors and impact on disease outcome. Acta Gastro-Enterologica Belgica, 77 (1), 41-6. |
VAN KEMSEKE, C. (2014). Constipation et troubles de la continence fécale chez le sujet âgé. Revue Médicale de Liège, 69 (5-6), 337-42. |
Benitez, J.-M., Meuwis, M.-A., REENAERS, C., VAN KEMSEKE, C., Meunier, P., & Louis, E. (2013). Role of endoscopy, cross-sectional imaging and biomarkers in Crohn's disease monitoring. Gut, 62 (12), 1806-16. doi:10.1136/gutjnl-2012-303957 |
Louis, E., REENAERS, C., Meuwis, M.-A., VAN KEMSEKE, C., LATOUR, P., CHAPELIER, N., WERTZ, S., COIMBRA MARQUES, C., MEUNIER, P., & Belaiche, J. (March 2012). Quinze ans d'anti-TNF dans la maladie de Crohn: comment tirer le meilleur de cette revolution therapeutique? Revue Médicale de Liège, 67 Spec No, 8-13. |
Louis, E., GAST, P., VAN KEMSEKE, C., & REENAERS, C. (2012). Commentary: endoscopic dilatation for stricturing Crohn's disease. Alimentary Pharmacology and Therapeutics, 36 (5), 494-6. doi:10.1111/j.1365-2036.2012.05209.x |
Louis, E., VAN KEMSEKE, C., LATOUR, P., Belaiche, J., & REENAERS, C. (2012). Genetique et environnement dans les maladies inflammatoires chroniques de l'intestin. Revue Médicale de Liège, 67 (5-6), 298-304. |
Louis, E., VAN KEMSEKE, C., & Reenaers, C. (2011). Necessity of phenotypic classification of inflammatory bowel disease. Best Practice and Research. Clinical Gastroenterology, 25 Suppl 1, 2-7. doi:10.1016/S1521-6918(11)70003-8 |
Van Kemseke, C. (2009). Sexually transmitted diseases and anorectum. Acta Gastro-Enterologica Belgica, 72 (4), 413-9. |
De Roover, A., Coimbra Marques, C., Detry, O., Van Kemseke, C., Squifflet, J.-P., Honore, P., & Meurisse, M. (27 September 2007). Pancreas graft drainage in recipient duodenum: Preliminary experience. Transplantation, 84 (6), 795-797. doi:10.1097/01.tp.0000281401.88231.da |
Van Kemseke, C., & Belaiche, J. (2004). Medical treatment of chronic anal fissure. Where do we stand on reversible chemical sphincterotomy? Acta Gastro-Enterologica Belgica, 67 (3, Jul-Sep), 265-271. |
Van Kemseke, C., Belaiche, J., Steeman, C., & Louis, E. (2003). Negative association between smoking and anti-saccharomyces cerevisiae antibodies in Crohn's disease. Acta Gastro-Enterologica Belgica, 66 (1, Jan-Mar), 1-6. |
Van Kemseke, C., Belaiche, J., & Louis, E. (August 2000). Frequently Relapsing Crohn's Disease Is Characterized by Persistent Elevation in Interleukin-6 and Soluble Interleukin-2 Receptor Serum Levels During Remission. International Journal of Colorectal Disease, 15 (4), 206-10. doi:10.1007/s003840000226 |
Van Kemseke, C., & Belaiche, J. (May 2000). Recommandations dans la prise en charge de l'Helicobacter pylori: point de vue recent de la Societe nationale francaise de Gastroenterologie. Revue Médicale de Liège, 55 (5), 345-9. |
Van Kemseke, C., & Belaiche, J. (July 1999). Controverses dans le traitement de l'Helicobacter pylori. Revue Médicale de Liège, 54 (7), 570-5. |
Belaiche, J., Van Kemseke, C., & Louis, E. (May 1999). Use of the Enteroscope for Colo-Ileoscopy: Low Yield in Unexplained Lower Gastrointestinal Bleeding. Endoscopy, 31 (4), 298-301. doi:10.1055/s-1999-17 |
Louis, E., Belaiche, J., Van Kemseke, C., Franchimont, D., de Groote, D., Geenen, V., & Mary, J. Y. (October 1997). A High Serum Concentration of Interleukin-6 Is Predictive of Relapse in Quiescent Crohn's Disease. European Journal of Gastroenterology and Hepatology, 9 (10), 939-44. doi:10.1097/00042737-199710000-00004 |
Louis, E., Franchimont, D., Lamproye, A., Van Kemseke, C., Schaaf-Lafontaine, N., Mahieu, P., & Belaiche, J. (September 1995). Systemic Immune Response after Rectocolonic Administration of Ovalbumin in Mice. International Archives of Allergy and Immunology, 108 (1), 19-23. doi:10.1159/000237112 |
Louis, E., Belaiche, J., Van Kemseke, C., Schaaf-Lafontaine, N., Mahieu, P., & Mary, J. Y. (August 1995). Soluble Interleukin-2 Receptor in Crohn's Disease. Assessment of Disease Activity and Prediction of Relapse. Digestive Diseases and Sciences, 40 (8), 1750-6. doi:10.1007/BF02212697 |
Louis, E., Lamproye, A., FRANCHIMONT, D., Van Kemseke, C., Schaaf-Lafontaine, N., MAHIEU, P., & Belaiche, J. (1995). Induction of cellular, but not humoral, tolerance to ovalbumin by direct injection into digestive tract segments or mesenteric lymph nodes in mice. Regional Immunology, 6, 251-256. |
Van Kemseke, C., & Krzesinski, J.-M. (1995). Curious association between methyldopa, hepatic cirrhosis and fibrosing alveolitis: a case report. European Journal of Internal Medicine, 6, 131. |